MEI PHARMA

MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company’s clinical development pipeline includes lead drug candidate Pracinostat, a potential best-in-class, oral histone deacetylase (HDAC) inhibitor. Pracinostat has been tested in more than 150 patients in multiple Phase I and exploratory Phase II clinical trials, including advanced hematologic malignancies such as myelodysplastic syndrome, acute myelo... id leukemia and myelofibrosis. The Company expects to initiate a randomized Phase II trial of Pracinostat in combination with standard-of-care in at least one hematologic malignancy toward the middle of 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. Results from a Phase I trial of intravenous ME-143 in heavily treated patients with solid refractory tumors were presented at the American Society of Clinical Oncology Annual Meeting in June 2012. A Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors is ongoing.

#SimilarOrganizations #People #Financial #Event #Website #More

MEI PHARMA

Social Links:

Industry:

Biopharma Biotechnology Medical

Founded:

2000-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.meipharma.com

Total Employee:

11+

Status:

Active

Contact:

858-792-6300

Email Addresses:

[email protected]

Total Funding:

160.36 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Font Awesome Global Site Tag Mobile Non Scaleable Content

Similar Organizations

ansun-biopharma-logo

Ansun BioPharma

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.

lineage-cell-therapeutics-logo

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

novavax-logo

Novavax

Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Advisors List

nick-glover_image

Nick Glover Board of Directors @ MEI Pharma
Board_member

Current Employees Featured

not_available_image

Leah R. Cann
Leah R. Cann Non-Executive Director @ MEI Pharma
Non-Executive Director

david-urso_image

David Urso
David Urso Chief Operating Officer, General Counsel & SVP Corporate Development @ MEI Pharma
Chief Operating Officer, General Counsel & SVP Corporate Development
2018-07-01

daniel-p-gold_image

Daniel P. Gold
Daniel P. Gold President & Chief Executive Officer @ MEI Pharma
President & Chief Executive Officer
2010-04-01

yomara-gomez-naiden_image

Yomara Gomez-Naiden
Yomara Gomez-Naiden Sr. VP, Quality @ MEI Pharma
Sr. VP, Quality
2022-02-01

tina-c-beamon_image

Tina C. Beamon
Tina C. Beamon Chief Compliance Officer @ MEI Pharma
Chief Compliance Officer
2021-06-01

brian-t-powl_image

Brian T. Powl
Brian T. Powl Senior Vice President Marketing @ MEI Pharma
Senior Vice President Marketing
2020-09-01

not_available_image

Christine A. White
Christine A. White Managing Director @ MEI Pharma
Managing Director

robert-mass_image

Robert Mass
Robert Mass Chief Medical Officer @ MEI Pharma
Chief Medical Officer

nick-glover_image

Nick Glover
Nick Glover Board of Directors @ MEI Pharma
Board of Directors
2013-01-01

alejandro-d-ricart_image

Alejandro D. Ricart
Alejandro D. Ricart SVP, clinical development @ MEI Pharma
SVP, clinical development
2022-01-01

Stock Details

Company's stock symbol is NASDAQ:MEIP

Investors List

camcapital_image

Key Employee Changes

Date	New article
2022-06-22	MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer
2022-02-07	MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments
2021-07-07	MEI Pharma Appoints Tina C. Beamon, J.D., as Chief Compliance Officer
2020-09-15	MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing

Official Site Inspections

http://www.meipharma.com Semrush global rank: 2.03 M Semrush visits lastest month: 10.38 K

Host Informations
Whois Informations

Loading ...